KAIST team develops neural chip to track Alzheimer's drug response
What happens in the brain after an Alzheimer's drug is administered? A joint research team led by KAIST has used a small, implantable neural chip to wirelessly monitor real-time changes in a neurotransmitter involved in memory and learning.
Read original article on The Medical News →Related news
-
Smart probe makes aggressive breast cancer cells glow during surgery
United Kingdom
-
Biomarkers identified for cytokine release syndrome risk after CAR T-cell therapy
United Kingdom
-
Immunotherapy combo extends survival for patients with aggressive small cell lung cancer, based on trial results
United Kingdom
-
Physical activity may help lower genetic risk of depression in adults
United Kingdom
-
Florida dengue cases nearly double a month after emergency declared
United Kingdom
-
AI chatbots may worsen symptoms in people with psychosis
United Kingdom
-
Simple drug adjustment reduces kidney damage during septic shock surgery
United Kingdom
-
AI chatbots can be a valuable health resource for older adults—if they embrace 'informed skepticism'
United Kingdom